:

Homeland Security

Osiris Nabs $225M DoD Contract for Acute Radiation Syndrome

DDN

Wednesday, January 9th, 2008

SHARE:

Osiris Therapeutics [OSIR] won a potential $224.7 million contract from the Defense Department for the development and possible purchase of Prochymal, an adult stem cell therapy, for the repair of gastrointestinal injury resulting from radiation exposure. Initially Osiris will receive $4.2 million this year to continue development of Prochymal for acute radiation syndrome (ARS). Once the Food and Drug Administration (FDA) approves the drug for ARS, the contract provides for the purchase of up to 20,000 doses, at $10,000 per…

Army

Army Plans To Initiate ISV-Heavy Competition Later This Year, Official Says

The Army is planning to initiate its competition to build the Infantry Squad Vehicle (ISV)-Heavy in the fourth quarter of this year, a senior acquisition official has said. Jesse Tolleson, […]

Senate Authorization Bill Restricts Building Navy Warships Overseas With Limited Exception For Auxiliaries

The Senate Armed Services Committee’s (SASC) version of the FY 2027 defense policy bill looks to cut the ability for the Trump administration to buy foreign-made warships, but still allow […]

Army

Army ‘Looking At Options’ For Supporting Munitions Boost Plans If Reconciliation Fails, Official Says

The Army is “looking at options” for how it would support planned boosts to munitions production if Congress doesn’t pass a reconciliation bill with the requested funding, a senior acquisition […]

Build Of At Least 45 MQ-9s By Start Of FY 2029 Required By SASC Bill

Down to an inventory of 135 MQ-9A Reapers due to the loss of two dozen aircraft in strikes on Iran, the Air Force would have to field at least 45 […]